EDRH
VRTX icon

Edmond de Rothschild Holding’s Vertex Pharmaceuticals VRTX Stock Holding History

Edmond de Rothschild Holding’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-9,000
Closed -$74.7K – 718
2024
Q1 		$74.7K Buy
+9,000
New +$3.8M ﹤0.01% 543

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Edmond de Rothschild Holding's VRTX Position: Q1 2026 in Review

Edmond de Rothschild Holding held its Vertex Pharmaceuticals (VRTX) position steady in Q1 2026 at 191 shares worth $85.3K. The position accounts for ﹤0.01% of the portfolio, ranked #424.

Edmond de Rothschild Holding first reported a position in VRTX in Q2 2015 and has held it in 44 quarters since. The position peaked at $22.5M in Q1 2017. 1,691 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Edmond de Rothschild Holding held 191 shares of Vertex Pharmaceuticals worth $85.3K as of Q1 2026.
  • Edmond de Rothschild Holding left its Vertex Pharmaceuticals share count unchanged in Q1 2026.
  • Vertex Pharmaceuticals made up ﹤0.01% of Edmond de Rothschild Holding's portfolio in Q1 2026, its #424 holding.
  • Edmond de Rothschild Holding first reported a position in Vertex Pharmaceuticals in Q2 2015 and has held it in 44 quarters since.
  • Edmond de Rothschild Holding's Vertex Pharmaceuticals position peaked at $22.5M in Q1 2017.
  • 1,691 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Edmond de Rothschild Holding's 13F filing for Q1 2026, filed 13 May 2026.